AI drug discovery market to grow 30% CAGR, to reach US$ 35 bn by 2034; Novo, Lilly, BMS forge deals

Data Compilation
#PharmaFlow

Pipeline Prospector Feb 2025: Bain buys Mitsubishi Tanabe for US$ 3.4 bn; Japan’s Ono gets FDA nod for rare joint tumor drug

Stock Recap
#PipelineProspector

(.+-.)-2-(p-Isobutylphenyl)propionic acid

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

98 API Suppliers, 63 USDMF, 13 CEP/COS, 4 JDMF, 6 EU WC, 93 KDMF, 37 NDC API, 38 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1147 FDF Dossiers, 320 FDA Orange Book, 332 Europe, 81 Canada, 15 Australia, 115 South Africa, 284 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG, TABLET;ORAL - 200MG, TABLET;ORAL - 200MG;30MG, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT, SUSPENSION;ORAL - 100MG/5ML, CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG, CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT, TABLET;ORAL - 38MG;200MG, TABLET;ORAL - 2MG;200MG;30MG, TABLET;ORAL - 4MG;200MG;10MG, TABLET;ORAL - 200MG;10MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 10 Rochem International Inc, 21 SPI Pharma, 22 DKSH, 2 Pharm-RX Chemical, 10 Faran Shimi Pharmaceutical, 12 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 2 Kewpie Corporation, 15 Nanjing Well Pharmaceutical, 3 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 3 Aeon Procare, 2 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 37 BASF, 1 Bioplus Life Sciences, 6 Clariant, 12 Corel Pharma Chem, 7 DFE Pharma, 2 Finar, 14 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 11 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 41 Roquette, 16 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 5 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

125 Fillers, Diluents & Binders, 63 Coating Systems & Additives, 52 Thickeners and Stabilizers, 48 Direct Compression, 44 Disintegrants & Superdisintegrants, 43 Solubilizers, 36 Controlled & Modified Release, 35 Granulation, 35 Topical, 34 Taste Masking, 34 Parenteral, 33 Film Formers & Plasticizers, 29 Lubricants & Glidants, 23 Chewable & Orodispersible Aids, 19 Emulsifying Agents, 19 Co-Processed Excipients, 15 Rheology Modifiers, 11 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 177 News #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 262 Regulatory FDF Prices

MARKET PLACE

91 APIs, 38 FDF Dossiers

PATENTS & EXCLUSIVITIES

24 US Patents, 4 US Exclusivities, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 2 USP, 27 Others

ANALYTICAL

2 BioAnalytical Methods, 1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Holder	DMF No.	Subject	Submission Date	Status	Type	GDUFA DMF Review	GDUFA Review Date	GDUFA Payment Date
24/02/2025	IOL Chemicals and Pharmaceuticals	India	IOL CHEMICALS AND PHARMACEUTICALS LTD	22431	IBUPROFEN USP	2009-01-15	Active	II	Complete	2014-06-13	2014-06-09
24/02/2025	Granules India Limited	India	GRANULES INDIA LTD	20606	COMPRESSO IBU 66S	2007-06-12	Active	II	N/A

(.+-.)-2-(p-Isobutylphenyl)propionic Acid

(.+-.)-2-(p-Isobutylphenyl)propionic acid

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

98 API Suppliers

63 USDMF

13 CEP/COS

4 JDMF

6 EU WC

93 KDMF

37 NDC API

38 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

INTERMEDIATES

3 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1147 FDF Dossiers

320 FDA Orange Book

332 Europe

81 Canada

15 Australia

115 South Africa

284 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG

TABLET;ORAL - 200MG

TABLET;ORAL - 200MG;30MG

CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT

SUSPENSION;ORAL - 100MG/5ML

CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG

CAPSULE;ORAL - 25MG;EQ 200MG FREE ACID AND POTASSIUM SALT

TABLET;ORAL - 38MG;200MG

TABLET;ORAL - 2MG;200MG;30MG

TABLET;ORAL - 4MG;200MG;10MG

TABLET;ORAL - 200MG;10MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

10 Rochem International Inc

21 SPI Pharma

22 DKSH

2 Pharm-RX Chemical

10 Faran Shimi Pharmaceutical

12 Boai NKY Pharmaceuticals Ltd

9 Gangwal Healthcare

2 Kewpie Corporation

15 Nanjing Well Pharmaceutical

3 Pfanstiehl

4 ACG Worldwide

12 Actylis

3 Aeon Procare

2 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

37 BASF

1 Bioplus Life Sciences

6 Clariant

12 Corel Pharma Chem

7 DFE Pharma

2 Finar

14 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

4 Kima Chemical

6 Lonza Capsugel

24 Microlex e.U

2 Nanjing Bold Chemical

2 Nomisma Healthcare

5 Novo Excipients

4 Pharmatrans-Sanaq

11 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd